LONG-TERM INTERVENTION EFFECTS ON BONE MARROW MORPHOLOGY IN MYELOFIBROSIS: PATIENTS TREATED WITH RUXOLITINIB AND BEST AVAILABLE THERAPY

被引：0
|
作者：
Kvasnicka, H. [1 ]
Thiele, J. [2 ]
Bueso-Ramos, C. E. [3 ]
Sung, W. [4 ]
Cortes, J. [3 ]
Kantarjian, H. M. [3 ]
Verstovsek, S. [3 ]
机构：
[1] Goethe Univ Frankfurt, Senckenberg Inst Pathol, Frankfurt, Germany
[2] Univ Cologne, Cologne, Germany
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Incyte Corp, Wilmington, DE USA
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S591
引用
收藏
页码：249 / 249
页数：1
相关论文
共 50 条
  • [1] Long-Term Effects of Ruxolitinib on Bone Marrow Morphology in Patients With Myelofibrosis and Comparison to Best Available Therapy
    Kvasnicka, Hans Michael
    Thiele, Juergen
    Bueso-Ramos, Carlos E.
    Sun, William
    Cortes, Jorge
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 : S155 - S155
  • [2] Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis
    Hans Michael Kvasnicka
    Jürgen Thiele
    Carlos E. Bueso-Ramos
    William Sun
    Jorge Cortes
    Hagop M. Kantarjian
    Srdan Verstovsek
    Journal of Hematology & Oncology, 11
  • [3] Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis
    Kvasnicka, Hans Michael
    Thiele, Juergen
    Bueso-Ramos, Carlos E.
    Sun, William
    Cortes, Jorge
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [4] CHANGES IN BONE MARROW MORPHOLOGY IN PATIENTS WITH MYELOFIBROSIS TREATED FOR UP TO 5 YEARS WITH EITHER RUXOLITINIB OR BEST AVAILABLE THERAPY
    Kvasnicka, H. M.
    Thiele, J.
    Bueso-Ramos, C. E.
    Sun, W.
    Cortes, J.
    Kantarjian, H. M.
    Verstovsek, S.
    HAEMATOLOGICA, 2014, 99 : 127 - 128
  • [5] Long-term bone marrow stromal changes in patients with myelofibrosis treated with ruxolitinib
    Kvasnicka, Hans Michael
    Thiele, Juergen
    Bueso-Ramos, Carlos E.
    Sun, William
    Cortes, Jorge
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S234 - S234
  • [6] Effects of Long-Term Ruxolitinib (RUX) on Bone Marrow (BM) Morphology in Patients with Myelofibrosis (MF) Enrolled in the COMFORT-I Study
    Kvasnicka, Hans Michael
    Thiele, Juergen
    Bueso-Ramos, Carlos E.
    Sun, William
    Naim, Ahmad
    Svaraman, Smitha
    Gao, Jessy
    Gotlib, Jason R.
    Gupta, Vikas
    Dao, Kim-Hien
    Talpaz, Moshe
    Winton, Elliott F.
    Harvey, Jimmie H., Jr.
    Verstovsek, Srdan
    BLOOD, 2016, 128 (22)
  • [7] Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis
    C N Harrison
    A M Vannucchi
    J-J Kiladjian
    H K Al-Ali
    H Gisslinger
    L Knoops
    F Cervantes
    M M Jones
    K Sun
    M McQuitty
    V Stalbovskaya
    P Gopalakrishna
    T Barbui
    Leukemia, 2016, 30 : 1701 - 1707
  • [8] Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis
    Harrison, C. N.
    Vannucchi, A. M.
    Kiladjian, J-J
    Al-Ali, H. K.
    Gisslinger, H.
    Knoops, L.
    Cervantes, F.
    Jones, M. M.
    Sun, K.
    McQuitty, M.
    Stalbovskaya, V.
    Gopalakrishna, P.
    Barbui, T.
    LEUKEMIA, 2016, 30 (08) : 1701 - 1707
  • [9] Characteristics and Outcome of Myelofibrosis Patients on Long-Term Ruxolitinib Therapy (≥3 years)
    Masarova, Lucia
    Bose, Prithviraj
    Pemmaraju, Naveen
    Zhou, Lingsha
    Pierce, Sherry A.
    Kantarjian, Hagop M.
    Estrov, Zeev E.
    Verstovsek, Srdan
    BLOOD, 2020, 136
  • [10] Health-related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy
    Harrison, Claire N.
    Mesa, Ruben A.
    Kiladjian, Jean-Jacques
    Al-Ali, Haifa-Kathrin
    Gisslinger, Heinz
    Knoops, Laurent
    Squier, Margaret
    Sirulnik, Andres
    Mendelson, Estella
    Zhou, Xiaolei
    Copley-Merriman, Catherine
    Hunter, Deborah S.
    Levy, Richard S.
    Cervantes, Francisco
    Passamonti, Francesco
    Barbui, Tiziano
    Barosi, Giovanni
    Vannucchi, Alessandro M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (02) : 229 - 239
12345